Skip to main content

Trials Determined to be Unavailable

NCT# Generic or Product Name Number of Inquiries Received Reason Trial is Not Available
NCT02670395 N/A 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT01704040 CNTO3157 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00574288 Daratumamab 1 Trial ongoing/completed <18 months ago
NCT01615029 Daratumamab 1 Trial ongoing/completed <18 months ago
NCT02477891 Daratumamab 1 Trial ongoing/completed <18 months ago
NCT02852837 Daratumamab 1 Trial ongoing/completed <18 months ago
NCT00799864 EDURANT®   1 Trial ongoing/completed <18 months ago
NCT00236990 ELMIRON® 1 Partner of Data Holder has not agreed to share
NCT02365597 Erdafitinib 1 Trial ongoing/completed <18 months ago
NCT01964651 FAAH inhibitor 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT01703481 FGFR kinase inhibitor 1 Trial is out of scope (i.e., Phase 1, OTC, etc.) and trial ongoing/completed <18 months ago
NCT02301234 Fulranumab 1 Trial ongoing/completed <18 months ago
NCT01484587 Guselkumab 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT02155192 Guselkumab 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00925574 Guselkumab 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT01866007 Guselkumab 2 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT01731951 Imetelstat 1 Trial ongoing/completed <18 months ago
NCT02598661 Imetelstat 2 Trial ongoing/completed <18 months ago
NCT00758030 INVEGA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00791349 INVEGA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00791622 INVEGA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: R092670-JPN-4) INVEGA® SUSTENNA® 1 Trial materials not available in English
NCT01559272 INVEGA® SUSTENNA® 1 Trial ongoing/completed <18 months ago
NCT01032629 INVOKANA® 3 Regulatory approval not yet received
NCT01989754 INVOKANA® 3 Regulatory approval not yet received
NCT00396565 PALIPERIDONE® 1 Trial materials not available in English
NCT00855335 PREZISTA® 1 Trial ongoing/completed <18 months ago
NCT01619527 PREZISTA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TMC114-C105) PREZISTA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TMC114-C114) PREZISTA® 2 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TMC114-C116) PREZISTA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TMC114-C143) PREZISTA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TMC114IFD1001) PREZISTA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00814801 RAZADYNE® 2 Trial materials not available in English
N/A
(sponsor ID: GAL-JPN-3)
RAZADYNE® 1 Trial materials not available in English
N/A (sponsor ID: GAL-PED-1001 (CR010954)) RAZADYNE® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: RIS-BEL-24) RISPERDAL® 1 Regulatory approval not yet received
N/A (sponsor ID: RIS-INT-26) RISPERDAL® 1 Data cannot be converted to electronic format
N/A (sponsor ID: RIS-INT-39) RISPERDAL® 1 Regulatory approval not yet received
N/A (sponsor ID: RIS-NED-9) RISPERDAL® 1 Regulatory approval not yet received
NCT00488631 SIMPONI® 3 Trial ongoing/completed <18 months ago
NCT00265122 STELARA® 1 Regulatory approval not yet received
NCT00771667 STELARA® 2 Regulatory approval not yet received
NCT01090427 STELARA® 1 Trial ongoing/completed <18 months ago and regulatory approval not yet received
NCT01369329 STELARA® 1 Regulatory approval not yet received
NCT01369342 STELARA® 1 Regulatory approval not yet received
NCT02359890 THERMOCOOL® SMARTTOUCH® (RF ablation treatment) 1 Trial ongoing/completed <18 months ago
N/A (sponsor ID: TRAM-PEDS-001) ULTRAM ® and ULTRAM® ER 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TRAM-PEDS-005) ULTRAM® and ULTRAM® ER 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
N/A (sponsor ID: TRAM-PEDS-006) ULTRAM® and ULTRAM® ER 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT00111319 VELCADE® 1 Data subject to partner agreement; researcher advised to contact partnering Data Holder
NCT00507416 VELCADE® 1 Data subject to partner agreement; researcher advised to contact partnering Data Holder
NCT00403767 XARELTO® 3 Partner of Data Holder has not agreed to share
NCT00809965 XARELTO® 1 Partner of Data Holder has not agreed to share and regulatory approval not yet received
NCT00440193 XARELTO® 1 Partner of Data Holder has not agreed to share
NCT00395772 XARELTO® 1 Partner of Data Holder has not agreed to share
NCT00439725 XARELTO® 1 Partner of Data Holder has not agreed to share
NCT00439777 XARELTO® 1 Partner of Data Holder has not agreed to share
NCT00494871 XARELTO® 1 Partner of Data Holder has not agreed to share
N/A Xylometazoline 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
NCT01343277 YONDELIS® 1 Trial ongoing/completed <18 months ago
NCT00887198 ZYTIGA® 5 Trial ongoing/completed <18 months ago
NCT02230046 ZYTIGA® 1 Trial is out of scope (i.e., Phase 1, OTC, etc.)
Total: 63 Total: 80

*Last update: September 6, 2017

Note: Inquiries for trials that were not sponsored by one of the YODA Project’s current partnering Data Holders are not included in the above.

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.